In a significant/important/landmark development for the treatment of spinal muscular atrophy (SMA), the Delhi High Court has upheld/approved/supported the regulatory approval/permission/sanction for the drug risdiplam https://xanderxlvg943304.activoblog.com/44652943/delhi-high-court-confirms-official-sanction-for-risdiplam-in-india